AI Verdict
VRTX has stronger fundamentals based on our AI analysis.
BAX vs VRTX Fundamental Comparison
| Metric | BAX | VRTX |
|---|---|---|
| Revenue | $11.2B | $12.0B |
| Net Income | $-957.0M | $4.0B |
| Net Margin | -8.5% | 32.9% |
| ROE | -15.6% | 21.2% |
| ROA | -4.8% | 15.4% |
| Current Ratio | 2.31x | 2.90x |
| Debt/Equity | 1.54x | 0.01x |
| EPS | $-1.87 | $15.32 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
BAX vs VRTX: Frequently Asked Questions
Is BAX or VRTX a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), VRTX has stronger fundamentals. BAX is rated SELL (80% confidence) while VRTX is rated BUY (86% confidence). This is not investment advice.
How does BAX compare to VRTX fundamentally?
BAXTER INTERNATIONAL INC has ROE of -15.6% vs VERTEX PHARMACEUTICALS INC / MA's 21.2%. Net margins are -8.5% vs 32.9% respectively.
Which stock pays higher dividends, BAX or VRTX?
BAX has a dividend yield of N/A or no dividend while VRTX has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in BAX or VRTX for long term?
For long-term investing, consider that BAX has SELL rating with 80% confidence, while VRTX has BUY rating with 86% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about BAX vs VRTX?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For BAX vs VRTX, the AI consensus favors VRTX based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.